These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10571158)

  • 21. Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compounds.
    Imamura H; Ohtake N; Shimizu A; Jona H; Sato H; Nagano R; Ushijima R; Yamada K; Hashizume T; Morishima H
    Bioorg Med Chem Lett; 2000 Jan; 10(2):109-13. PubMed ID: 10673091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antibacterial activity of 1-substituted-methyl carbapenems.
    Sendo Y; Kii M; Sakanoue M; Motokawa K; Kimura Y
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2410-8. PubMed ID: 1446363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1153-5. PubMed ID: 18180353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392.
    Ratcliffe RW; Wilkening RR; Wildonger KJ; Waddell ST; Santorelli GM; Parker DL; Morgan JD; Blizzard TA; Hammond ML; Heck JV; Huber J; Kohler J; Dorso KL; St Rose E; Sundelof JG; May WJ; Hammond GG
    Bioorg Med Chem Lett; 1999 Mar; 9(5):679-84. PubMed ID: 10201828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
    Kobayashi Y
    J Infect Chemother; 2005 Oct; 11(5):259-61. PubMed ID: 16258825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Lee CS; Lee JS; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationship of 2-(5-substituted pyrrolidin-4-ylthio)-1 beta-carbapenems.
    Lee HW; Kim EN; Kang TW; Ahn SK; Choi NH; Kim JW; Hong CI
    J Antibiot (Tokyo); 1997 Dec; 50(12):1078-82. PubMed ID: 9510920
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
    Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
    Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolidinopyrrolidin-3-ylthio)carbapenems and related compounds.
    Oh CH; Cho HW; Lee IK; Gong JY; Choi JH; Cho JH
    Arch Pharm (Weinheim); 2002 Apr; 335(4):152-8. PubMed ID: 12112035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
    Glinka TW; Cho A; Zhang ZJ; Ludwikow M; Griffith D; Huie K; Hecker SJ; Dudley MN; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1045-52. PubMed ID: 11132949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in vitro antibacterial activity.
    Kim SJ; Park HB; Lee JS; Jo NH; Yoo KH; Baek D; Kang BW; Cho JH; Oh CH
    Eur J Med Chem; 2007 Sep; 42(9):1176-83. PubMed ID: 17418453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain.
    Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel 1beta-methylcarbapenems having a new moiety at C-2.
    Kang YK; Shin KJ; Yoo KH; Seo KJ; Park SY; Kim DJ; Park SW
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2385-90. PubMed ID: 10476874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Naphthylcarbapenems: broad spectrum antibiotics with enhanced potency against MRSA.
    Greenlee ML; DiNinno F; Herrmann JJ; Jaworsky C; Muthard DA; Salzmann TN
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2893-6. PubMed ID: 10522713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry.
    Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ
    J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.